In ₹ Crore except Per Share 12 Months Ending | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | 78.7 | 81.0 | 95.5 | 111.4 | 100.7 | 100.8 | |
| Other Income | 0.7 | 1.1 | 3.9 | 1.6 | 1.7 | 0.9 | |
| Total Income | 79.4 | 82.1 | 99.4 | 112.9 | 102.4 | 101.7 | |
| Expenses | |||||||
| + Cost of Materials Consumed | 47.9 | 50.6 | 56.0 | 68.1 | 53.1 | 56.2 | |
| + Changes in Inventories | 0.9 | -0.9 | 1.0 | -2.5 | 2.4 | 0.1 | |
| + Employee Benefit Expense | 4.8 | 5.4 | 6.5 | 8.1 | 8.1 | 8.4 | |
| + Finance Costs | 1.1 | 1.0 | 0.9 | 0.8 | 0.8 | 0.7 | |
| + Depreciation & Amortisation | 3.2 | 2.8 | 4.2 | 5.3 | 5.6 | 6.0 | |
| + Other Expenses | 8.0 | 8.8 | 10.3 | 10.7 | 11.4 | 10.3 | |
| Total Expenses | 65.9 | 67.7 | 78.9 | 90.4 | 81.5 | 81.7 | |
| EBITDA | 17.1 | 17.1 | 21.7 | 27.1 | 25.6 | 25.8 | |
| EBIT | 13.9 | 14.3 | 17.5 | 21.8 | 20.1 | 19.9 | |
| Profit | |||||||
| PBT before Exceptional Items | 13.5 | 14.4 | 20.4 | 22.5 | 20.9 | 20.0 | |
| + Exceptional Items | -0.0 | 0.0 | 0.0 | -0.0 | 0.0 | 0.0 | |
| Pretax Income | 13.5 | 14.4 | 20.4 | 22.5 | 20.9 | 20.0 | |
| + Current Tax | 2.5 | 2.6 | 3.4 | 4.0 | 3.3 | 3.6 | |
| + Deferred Tax | 0.1 | -0.3 | 0.4 | -0.1 | 0.4 | -0.1 | |
| Tax Expense | 2.6 | 2.3 | 3.8 | 4.0 | 3.7 | 3.5 | |
| Net Income | 10.9 | 12.1 | 16.7 | 18.5 | 17.2 | 16.5 | |
| + Net Income — Continuing Ops | 10.9 | 12.1 | 16.7 | 18.5 | 17.2 | 16.5 | |
| + Other Comprehensive Income | 0.0 | 0.0 | 0.2 | 0.2 | -0.0 | -0.1 | |
| Total Comprehensive Income | 10.9 | 12.1 | 16.8 | 18.7 | 17.2 | 16.4 | |
| Per Share | |||||||
| Basic EPS | 5.44 | 4.55 | 6.31 | 7.02 | 6.45 | 6.18 | |
| Diluted EPS | 5.44 | 4.55 | 6.31 | 7.02 | 6.45 | 6.18 | |
| Other Comprehensive Income — detail | |||||||
| + Other Comprehensive Income | — | — | 0.2 | 0.2 | -0.0 | -0.1 | |
| + Items NOT to be Reclassified to P&L | — | — | 0.2 | 0.2 | -0.0 | -0.1 | |
| Per Share — as-filed variants | |||||||
| Basic EPS — Continuing Operations | 5.44 | 4.55 | 6.31 | 7.02 | 6.45 | 6.18 | |
| Diluted EPS — Continuing Operations | 5.44 | 4.55 | 6.31 | 7.02 | 6.45 | 6.18 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||||
| Related-party Transactions — During the Period | 66.8 | — | 18,46,660.9 | — | 13.2 | — | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | |||||||
| Gross Profit | 29.9 | 31.3 | 38.5 | 45.8 | 45.1 | 44.5 | |
| Gross Margin % | 38.02 | 38.61 | 40.30 | 41.17 | 44.82 | 44.15 | |
| Adjusted (ex-Exceptional Items) — derived | |||||||
| Pretax Income (Adjusted, as filed) | 13.5 | 14.4 | 20.4 | 22.5 | 20.9 | 20.0 | |
| − Exceptional Items (reconciliation) | -0.0 | 0.0 | 0.0 | -0.0 | 0.0 | 0.0 | |
| Net Income Adj (tax-effected) | 10.9 | 12.1 | 16.7 | 18.6 | 17.2 | 16.5 | |
| EPS Adj | 5.44 | 4.55 | 6.31 | 7.03 | 6.45 | 6.18 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |
| Paid Up Equity Capital | 2.0 | 26.6 | 26.6 | 26.6 | 26.6 | 26.6 | |